Article
Overestimation of genetic risks owing to small sample sizes in cardiovascular studies.
Clinical genetics - 1 Jul 2003
Morgan T M, Coffey C S, Krumholz H M
Abstract excerpt
We sought evidence of publication bias to explain conflicting findings in studies of angiotensin-converting enzyme deletion polymorphism (ACE D) and glycoprotein IIIa PlA2 (PLA2) polymorphism and the risk of myocardial infarction. Factor 5 Leiden (F5L), a well-established thrombotic risk factor, served as an internal comparison. We conducted systematic reviews of published studies involving ACE D, PLA2, F5L and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
